Stay updated on Ixazomib Citrate for Relapsed Myeloma Clinical Trial
Sign up to get notified when there's something new on the Ixazomib Citrate for Relapsed Myeloma Clinical Trial page.

Latest updates to the Ixazomib Citrate for Relapsed Myeloma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedPublications note is now described as automatically filled from PubMed, and the Revision label updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check18 days agoChange DetectedRemoved a government funding status notice banner from the page; this is a minor administrative change that does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check40 days agoChange DetectedNo significant changes detected between the two screenshots. The page content and structure appear unchanged, continuing to present the Study Details for NCT01415882.SummaryDifference0.2%

- Check62 days agoChange DetectedCore content updated to inform users about funding-related operating status and current NIH Clinical Center openness; version updated from v3.1.0 to v3.2.0.SummaryDifference2%

- Check69 days agoChange Detected- Added revision tag v3.1.0 and removed the Plasma cell myeloma resource from the Genetic and Rare Diseases Information Center list. Overall: minor content update with a resource removal.SummaryDifference0.3%

- Check83 days agoChange DetectedAdds an estimated Last Update Posted and Revision: v3.0.2, replacing Last Update Posted and Revision: v3.0.1; also removes the Back to Top link.SummaryDifference0.1%

Stay in the know with updates to Ixazomib Citrate for Relapsed Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixazomib Citrate for Relapsed Myeloma Clinical Trial page.